EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems

Juan Wang, Lijuan Xing, Yang Song, Yue Yang, Yinzhuo Zhang, Haoxiang Ma, Benyu Su, Luoxuan Su, Chao Ma, Mingyan Liu, Ke Du

Journal of Advanced Research · 2025-12 · 78 · 733-756

DOI: 10.1016/j.jare.2025.06.024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Advanced Research, 2025-12. Verfasst von Juan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Department of Pharmacology, China Medical University, Shenyang 110122, China. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Drug Delivery Systems, Neuroinflammatory Diseases, Receptors, Fibroblast Growth Factor. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Medical University, Liaoning Province Supported China Medical University High-quality Development Fund Project in 2022, Liaoning Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fibroblast Growth Factors and Fibroblast Growth Factor Receptors (FGFs/FGFRs) constitute a complex and diverse signaling system crucial in various biological processes, such as cell proliferation, differentiation, migration, and survival. Dysregulation of the FGFs/FGFRs system plays a key role in the progression of neurological diseases through the neuroinflammatory process. FGFs/FGFRs have become a key target of novel drugs in recent years for the treatment of neurological diseases. Notably, drug delivery systems can enhance the clinical therapeutic efficacy of these drugs. AIM OF REVIEW: This review highlights the critical role of FGFs/FGFRs in various neuroinflammatory diseases and provides an overview of the current research on FGFs/FGFRs-targeted therapeutic drugs, their novel delivery systems, and development potential. Advances in this field can enhance further application of potential drugs, offering new insights and approaches for treating neuroinflammatory diseases, thus reducing the incidence and progression. KEY SCIENTIFIC CONCEPTS OF REVIEW: Moreover, this review summarizes the structure and function of FGFs/FGFRs, elucidates the signaling pathways through which the FGFs/FGFRs system is involved in neuroinflammatory diseases (Alzheimer's disease (AD) and Parkinson's disease (PD)), and emphasizes the key role of FGFs/FGFRs system in disease progression. Furthermore, the current anti-inflammatory drugs targeting the FGFs/FGFRs system, including direct FGF modulators and indirect FGF modulators, have been summarized. The positive impact of the development of novel drug delivery systems, such as liposomes, microspheres, and hydrogels, on therapeutic outcomes has also been discussed. Therefore, this review may offer guidance and insights for the management of neuroinflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth FactorsDrug Delivery SystemsNeuroinflammatory DiseasesReceptors, Fibroblast Growth FactorHumansSignal TransductionAnimalsAlzheimer Disease

Stichwörter der Autor:innen

Delivery systemDrugFibroblast growth factorFibroblast growth factor receptorNeuroinflammatory diseases

Substanzen

Fibroblast Growth FactorsReceptors, Fibroblast Growth Factor

Autor:innen und Institutionen

  • School of Pharmacy, Department of Pharmacology, China Medical University, Shenyang 110122, China.
  • Precision Laboratory of Panjin Central Hospital, Panjin 124000, China.
  • School of Medical Humanities, China Medical University, Shenyang 110122, China.
  • Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: machao_syphu@163.…
  • School of Pharmacy, Department of Pharmacology, China Medical University, Shenyang 110122, China. Electronic address: liumy_cmu@163.com.
  • School of Pharmacy, Department of Pharmacology, China Medical University, Shenyang 110122, China. Electronic address: kdu@cmu.edu.cn.

Förderung

  • China Medical University
  • Liaoning Province Supported China Medical University High-quality Development Fund Project in 2022
  • Liaoning Provincial Natural Science Foundation

Zitieren

APA

Wang, J., Xing, L., Song, Y., Yang, Y., Zhang, Y., Ma, H., Su, B., Su, L., Ma, C., Liu, M., & Du, K. (2025). FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems. Journal of Advanced Research, 78, 733-756. https://doi.org/10.1016/j.jare.2025.06.024

Vancouver

Wang J, Xing L, Song Y, Yang Y, Zhang Y, Ma H, et al. FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems. Journal of Advanced Research. 2025;78:733-756. doi:10.1016/j.jare.2025.06.024

BibTeX
@article{Wang2025,
  author = {Wang, Juan and Xing, Lijuan and Song, Yang and Yang, Yue and Zhang, Yinzhuo and Ma, Haoxiang and Su, Benyu and Su, Luoxuan and Ma, Chao and Liu, Mingyan and Du, Ke},
  title = {FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems},
  journal = {Journal of Advanced Research},
  year = {2025},
  volume = {78},
  pages = {733--756},
  doi = {10.1016/j.jare.2025.06.024}
}
Kostenlos starten →